Abstract
Asia-Oceania is a diverse region that comprises roughly 65% of the global population at risk for malaria. In 2016 WHO estimated the number of malaria cases across the Asia-Oceania to be 17 million, which is only a small part (8%) of the total global malaria burden, and the number of cases is shrinking rapidly. Most countries have brought their cases down to the point where elimination is in sight. Plasmodium vivax (P. vivax) is becoming the dominant malaria species in many of those countries, where malaria occurs in hot spots of transmission frequently along international borders. The challenge is now to concentrate on those areas. This chapter reviews the situation in various areas of the Region and focuses on a number of important issues, including the prevalence of P. vivax and drug-resistant malaria.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Newby G, Bennett A, Larson E et al (2016) The path to eradication: a progress report on the malaria-eliminating countries. Lancet 387:1775–1784
World Health Organization (2015) Global Technical Strategy for Malaria 2016–2030. World Health Organization, Geneva
World Health Organization Regional Office for the Eastern Mediterranean (2017) Regional Malaria Action Plan 2016–2020—Towards a Malaria-Free Region. WHO Regional Office for the Eastern Mediterranean, Cairo
World Health Organization South-East Asia Regional Office (2017) Regional Action Plan 2017-2013. World Health Organization, New Delhi
World Health Organization (2015) World Malaria Report 2015. World Health Organization, Geneva
World Health Organization (2017) World Malaria Report 2017. World Health Organization, Geneva
World Health Organization Regional Office for the Western Pacific (2017) Regional Framework for Malaria Control and Elimination in the Western Pacific (2016-2020). World Health Organization, Manila, Philippines
World Health Organization (2016) World Malaria Report 2016. World Health Organization, Geneva
Department of Disease Control Ministry of Public Health Thailand. Thailand Malaria Elimination Program; online statistics. http://203.157.41.215/malariaR10/index_newversion.php
Singh B, Kim Sung L, Matusop A et al (2004) A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 363:1017–1024
Singh B, Daneshvar C (2013) Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev 26:165–184
Barber BE, Grigg MJ, William T et al (2017) The treatment of Plasmodium knowlesi malaria. Trends Parasitol 33:242–253
Price RN, von Seidlein L, Valecha N et al (2014) Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 14:982–991
Leang R, Barrette A, Bouth DM et al (2013) Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob Agents Chemother 57:818–826
Leang R, Ros S, Duong S et al (2013) Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia. Malar J 12:343
Moiz B (2013) A review of G6PD deficiency in Pakistani perspective. J Pak Med Assoc 63(4):501–503
Surjadjaja C, Surya A, Baird JK (2016) Epidemiology of Plasmodium vivax in Indonesia. Am J Trop Med Hyg 95:121–132
Adeel AA, Saeed NA, Aljasari A et al (2015) High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen. Malar J 14:449
Ministry of Health and Welfare India (2013) Diagnosis and treatment of malaria Directorate of National Vector Borne Disease Control Programme (NVBDCP). Directorate General Health Services
Mishra N, Kaitholia K, Srivastava B et al (2014) Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India. Malar J 13:284
Wongsrichanalai C, Pickard AL, Wernsdorfer WH et al (2002) Epidemiology of drug-resistant malaria. Lancet Infect Dis 2:209–218
Vijaykadga S, Rojanawatsirivej C, Cholpol S et al (2006) In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Tropical Med Int Health 11:211–219
Ariey F, Witkowski B, Amaratunga C et al (2014) A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50–55
World Health Organization Global Malaria Programme (2018) Artemisinin resistance and artemisinin-based combination therapy efficacy. Status report. Geneva. https://apps.who.int/iris/bitstream/handle/10665/274362/WHO-CDS-GMP-2018.18-eng.pdf?ua=1
Amaratunga C, Lim P, Suon S et al (2016) Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis 16:357–365
Duru V, Witkowski B, Menard D (2016) Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: A major challenge for malaria elimination in Cambodia. Am J Trop Med Hyg 95:1228–1238
Thanh NV, Thuy-Nhien N, Tuyen NT et al (2017) Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam. Malar J 16:27
Menard D, Khim N, Beghain J et al (2016) A worldwide map of Plasmodium falciparum K13-Propeller polymorphisms. N Engl J Med 374:2453–2464
Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM et al (2015) Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis 211(5):670–679. https://doi.org/10.1093/infdis/jiu491
Acknowledgments
The following individuals have contributed to this manuscript: Ghasem Zamani, Mohammad Sami Nahzat, Mya S. Ngon, Preecha Prempree, Dysoley Lek, and Akira Kaneko. We are also grateful to the Bureau of Vector Borne Disease Control, Department of Disease Control, Thai Ministry of Public Health, for their support.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Wongsrichanalai, C., Kurdova-Mintcheva, R., Palmer, K. (2019). Current Malaria Situation in Asia-Oceania. In: Ariey, F., Gay, F., Ménard, R. (eds) Malaria Control and Elimination. Methods in Molecular Biology, vol 2013. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9550-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9550-9_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9549-3
Online ISBN: 978-1-4939-9550-9
eBook Packages: Springer Protocols